Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Igor Elman

Showing results (101-110 of 147) with videos related to

Pageof 15
Sort By:
Brain : a Journal of Neurology|June 19, 2010
Alterations in brain structure and functional connectivity in prescription opioid-dependent patientsJaymin Upadhyay, Nasim Maleki, Jennifer Potter, et al.
International Journal of Spine Surgery|July 11, 2025
Opioid-Induced Hyperalgesia and Inflammaging in the Management of Spine Pain: The Case for Genetically Directed Dopamine HomeostasisKai-Uwe Lewandrowski, Rossano Kepler Alvim Fiorelli, Sergio Schmidt, et al.
EC Psychology and Psychiatry|February 1, 2024
Evidence Based Clinical Analytics Supporting the Genetic Addiction Risk Severity (GARS) Assessment to Early Identify Probands in PreaddictionKenneth Blum, Abdalla Bowirrat, Panayotis K Thanos, et al.
Clinical and Experimental Psychology|August 10, 2023
Evidence for the <i>DRD2</i> Gene as a Determinant of Reward Deficiency Syndrome (RDS)Kenneth Blum, Abdala Bowirrat, Igor Elman, et al.
Journal of Personalized Medicine|December 29, 2022
Genetic Addiction Risk Severity Assessment Identifies Polymorphic Reward Genes as Antecedents to Reward Deficiency Syndrome (RDS) Hypodopaminergia's Effect on Addictive and Non-Addictive Behaviors in a Nuclear FamilyCatherine A Dennen, Kenneth Blum, Abdalla Bowirrat, et al.
Substance Abuse and Rehabilitation|January 31, 2025
Response to the SAMHSA Clinical Advisory: Considerations for Genetic Testing in the Assessment of Substance Use Disorder RiskRichard Paul Green, Kenneth Blum, Kai Uwe Lewandrowski, et al.
International Journal of Environmental Research and Public Health|November 13, 2021
Reward Deficiency Syndrome (RDS): A Cytoarchitectural Common Neurobiological Trait of All AddictionsKenneth Blum, Abdalla Bowirrat, Eric R Braverman, et al.
Journal of Personalized Medicine|April 3, 2021
A Novel Precision Approach to Overcome the "Addiction Pandemic" by Incorporating Genetic Addiction Risk Severity (GARS) and Dopamine Homeostasis RestorationKenneth Blum, Shan Kazmi, Edward J Modestino, et al.
Heliyon|August 23, 2023
Personalized repetitive transcranial magnetic stimulation (prtms®) for post-traumatic stress disorder (ptsd) in military combat veteransMilan T Makale, Shaghayegh Abbasi, Chad Nybo, et al.
Acta Scientific Neurology|August 29, 2025
Is It Scientifically Possible To 'Cure" Reward Deficiency Syndrome (RDS) Via Transplice Molecular Genetic Technology?Kenneth Blum, Alireza Sharafshah, Kai -Uwe-Lewandowski, et al.
Pageof 15

Showing results (101-110 of 147) with videos related to

Sort By:
Pageof 15
Brain : a Journal of Neurology|June 19, 2010
Alterations in brain structure and functional connectivity in prescription opioid-dependent patientsJaymin Upadhyay, Nasim Maleki, Jennifer Potter, et al.
International Journal of Spine Surgery|July 11, 2025
Opioid-Induced Hyperalgesia and Inflammaging in the Management of Spine Pain: The Case for Genetically Directed Dopamine HomeostasisKai-Uwe Lewandrowski, Rossano Kepler Alvim Fiorelli, Sergio Schmidt, et al.
EC Psychology and Psychiatry|February 1, 2024
Evidence Based Clinical Analytics Supporting the Genetic Addiction Risk Severity (GARS) Assessment to Early Identify Probands in PreaddictionKenneth Blum, Abdalla Bowirrat, Panayotis K Thanos, et al.
Clinical and Experimental Psychology|August 10, 2023
Evidence for the <i>DRD2</i> Gene as a Determinant of Reward Deficiency Syndrome (RDS)Kenneth Blum, Abdala Bowirrat, Igor Elman, et al.
Journal of Personalized Medicine|December 29, 2022
Genetic Addiction Risk Severity Assessment Identifies Polymorphic Reward Genes as Antecedents to Reward Deficiency Syndrome (RDS) Hypodopaminergia's Effect on Addictive and Non-Addictive Behaviors in a Nuclear FamilyCatherine A Dennen, Kenneth Blum, Abdalla Bowirrat, et al.
Substance Abuse and Rehabilitation|January 31, 2025
Response to the SAMHSA Clinical Advisory: Considerations for Genetic Testing in the Assessment of Substance Use Disorder RiskRichard Paul Green, Kenneth Blum, Kai Uwe Lewandrowski, et al.
International Journal of Environmental Research and Public Health|November 13, 2021
Reward Deficiency Syndrome (RDS): A Cytoarchitectural Common Neurobiological Trait of All AddictionsKenneth Blum, Abdalla Bowirrat, Eric R Braverman, et al.
Journal of Personalized Medicine|April 3, 2021
A Novel Precision Approach to Overcome the "Addiction Pandemic" by Incorporating Genetic Addiction Risk Severity (GARS) and Dopamine Homeostasis RestorationKenneth Blum, Shan Kazmi, Edward J Modestino, et al.
Heliyon|August 23, 2023
Personalized repetitive transcranial magnetic stimulation (prtms®) for post-traumatic stress disorder (ptsd) in military combat veteransMilan T Makale, Shaghayegh Abbasi, Chad Nybo, et al.
Acta Scientific Neurology|August 29, 2025
Is It Scientifically Possible To 'Cure" Reward Deficiency Syndrome (RDS) Via Transplice Molecular Genetic Technology?Kenneth Blum, Alireza Sharafshah, Kai -Uwe-Lewandowski, et al.
Pageof 15